Brain

International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly

NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association…

5 months ago

Major Breakthrough In Telepathic Human-AI Communication

MindSpeech decodes seamless thoughts into text for the first time LONDON, Aug. 15, 2024 /PRNewswire/ -- A team of academics…

5 months ago

Brain-CA Technologies Secures Patents for Innovative AI based on Cellular Automata

Brain-CA Technologies has secured patents for a new AI solution based on Cellular Automata that will revolutionize the AI industry.  …

5 months ago

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14,…

5 months ago

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership

Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s diseaseROCHESTER,…

5 months ago

Zeto Among America’s Fastest-Growing Private Companies on the 2024 Inc. 5000 List

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. revealed today that Zeto, Inc. ranks No. 1311 on the 2024 Inc.…

5 months ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…

5 months ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

The ISO 13485 certification is a validation of the Company’s robust quality systemBRAINTREE, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) --…

5 months ago

Notice of Nexstim Plc’s Half-Year Report H1 2024

Press release, Helsinki, 13 August 2024 at 3 PM (EEST) Notice of Nexstim Plc’s Half-Year Report H1 2024 Nexstim Plc…

5 months ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Appointed Dr. Amanda Banks, a tenured physician and biotech leader, as Chief Development Officer to lead clinical strategy and executionExpanded…

5 months ago